标题 |
64O Lenvatinib plus pembrolizumab, pemetrexed, and a platinum (len + pembro + chemo) as first-line therapy for metastatic non squamous non-small cell lung cancer (NSCLC): Phase III LEAP-006 study
|
网址 | |
DOI |
10.1016/j.iotech.2023.100536
doi
|
其它 |
期刊:Immuno-oncology technology 作者:Roy S. Herbst; Byoung Chul Cho; Caicun Zhou; Mauricio Burotto; Manuel Cobo; et al 出版日期:2023-12-01 |
求助人 | |
下载 | 暂无链接,等待应助者上传 |